Home
ARTL
ARTL News

Latest Artelo Biosciences Inc. (ARTL) News on September 13, 2025

Alphabet downgraded, Boeing upgraded: Wall Street's top analyst calls

The Fly

5 days ago

Alphabet downgraded, Boeing upgraded: Wall Street's top analyst calls

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

GlobeNewswire

8 days ago

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

MT Newswires

2 months ago

Artelo Biosciences Says Study of Non-Opioid Pain Treatment Shows Positive Results; Shares Climb

Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

GlobeNewswire

2 months ago

Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain

Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing

GlobeNewswire

3 months ago

Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing

Artelo Biosciences Announces Reverse Stock Split

GlobeNewswire

3 months ago

Artelo Biosciences Announces Reverse Stock Split

Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study

GlobeNewswire

3 months ago

Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study

New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression

GlobeNewswire

3 months ago

New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

GlobeNewswire

4 months ago

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12’s Effectiveness in Treating Psoriasis

GlobeNewswire

5 months ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12’s Effectiveness in Treating Psoriasis

Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025

GlobeNewswire

5 months ago

Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025

Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

GlobeNewswire

6 months ago

Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®

GlobeNewswire

7 months ago

Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®

Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland

GlobeNewswire

7 months ago

Artelo Biosciences to Present its New Data on ART12.11 Tablets Compared to Epidiolex at the IMCCB-25 Conference in Bern, Switzerland

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12

GlobeNewswire

8 months ago

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12

Artelo presents Phase 1 data with ART27.13 in cancer-related anorexia

TipRanks

9 months ago

Artelo presents Phase 1 data with ART27.13 in cancer-related anorexia

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia

GlobeNewswire

9 months ago

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit

GlobeNewswire

10 months ago

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium

GlobeNewswire

10 months ago

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

10 months ago

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program

GlobeNewswire

10 months ago

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

GlobeNewswire

a year ago

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

GlobeNewswire

a year ago

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

GlobeNewswire

a year ago

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

GlobeNewswire

a year ago

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

GlobeNewswire

a year ago

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society

GlobeNewswire

a year ago

Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society

Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24

GlobeNewswire

a year ago

Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24

Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th

GlobeNewswire

a year ago

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

GlobeNewswire

a year ago

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time

GlobeNewswire

a year ago

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

GlobeNewswire

a year ago

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge

GlobeNewswire

2 years ago

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge

ACCESSWIRE

2 years ago

Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th

HeartSciences Appoints New Scientific Advisory Board Member

GlobeNewswire

2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

15 High Quality Flannel Shirts for Men

Insider Monkey

2 years ago

15 High Quality Flannel Shirts for Men

Forza X1, Inc. Conducts First Foundation Concrete Pour at Future North Carolina Facility

ACCESSWIRE

2 years ago

Forza X1, Inc. Conducts First Foundation Concrete Pour at Future North Carolina Facility

BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference

GlobeNewswire

2 years ago

BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference

$MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene$

GlobeNewswire

2 years ago

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

OMNIQ Corp. (NASDAQ:OMQS): Are Analysts Optimistic?

Simply Wall St.

2 years ago

OMNIQ Corp. (NASDAQ:OMQS): Are Analysts Optimistic?

Globus Maritime Limited Announces the Delivery of a 2024-Built Ultramax Dry Bulk Vessel “Glbs Hero,” Expanding Fleet to Seven Vessels

GlobeNewswire

2 years ago

Globus Maritime Limited Announces the Delivery of a 2024-Built Ultramax Dry Bulk Vessel “Glbs Hero,” Expanding Fleet to Seven Vessels

Caravelle, a model of Sino-French co-operation, was praised by many media at the Davos Summit 2024

PR Newswire

2 years ago

Caravelle, a model of Sino-French co-operation, was praised by many media at the Davos Summit 2024

Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround

Zacks

2 years ago

Down -33.01% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

GlobeNewswire

2 years ago

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

Chuck Royce Increases Stake in Express, Inc.

GuruFocus.com

2 years ago

Chuck Royce Increases Stake in Express, Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

GlobeNewswire

2 years ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

GlobeNewswire

2 years ago

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach

Tigo Energy to Lead Residential Solar Solutions Discussion at Intersolar North America 2024

Business Wire

2 years ago

Tigo Energy to Lead Residential Solar Solutions Discussion at Intersolar North America 2024

ETAO Announces receiving a staff determination - Delinquency letter from Nasdaq

PR Newswire

2 years ago

ETAO Announces receiving a staff determination - Delinquency letter from Nasdaq

Avikus, Forza X1, Inc. and Twin Vee PowerCats Co. Announce Plans for the Future of Recreational Boating with Autonomous A.I. Technology Partnership

ACCESSWIRE

2 years ago

Avikus, Forza X1, Inc. and Twin Vee PowerCats Co. Announce Plans for the Future of Recreational Boating with Autonomous A.I. Technology Partnership

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note

Business Wire

2 years ago

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note

Tigo Energy Strengthens Solar Rapid Shutdown Technology Patent Portfolio

Business Wire

2 years ago

Tigo Energy Strengthens Solar Rapid Shutdown Technology Patent Portfolio

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

PR Newswire

2 years ago

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

3 Stocks Set to Soar 68% to 200% Higher

InvestorPlace

2 years ago

3 Stocks Set to Soar 68% to 200% Higher

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12

GlobeNewswire

2 years ago

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12

Arizona Distilling Co. Opens Second Location in Downtown Mesa

Business Wire

2 years ago

Arizona Distilling Co. Opens Second Location in Downtown Mesa

Business Wire

2 years ago

MariaDB Files Form 10-K Annual Report

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

InvestorPlace

2 years ago

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

PR Newswire

2 years ago

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

Meta Materials Announces Proposed Class Actions Settlement

ACCESSWIRE

2 years ago

Meta Materials Announces Proposed Class Actions Settlement

Express Expands Collegiate Athlete Style Ambassador Program

Business Wire

2 years ago

Express Expands Collegiate Athlete Style Ambassador Program

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

GlobeNewswire

2 years ago

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

Yoshitsu Co., Ltd to Report First Six Months of Fiscal Year 2024 Financial Results on Friday, December 22, 2023

GlobeNewswire

2 years ago

Yoshitsu Co., Ltd to Report First Six Months of Fiscal Year 2024 Financial Results on Friday, December 22, 2023

Phoenix New Media Limited's (NYSE:FENG) Share Price Is Matching Sentiment Around Its Revenues

Simply Wall St.

2 years ago

Phoenix New Media Limited's (NYSE:FENG) Share Price Is Matching Sentiment Around Its Revenues

MariaDB Finalizes Spinoff of SkySQL

Business Wire

2 years ago

MariaDB Finalizes Spinoff of SkySQL

Iteris Launches Cutting-Edge Integrated Detection and Connected Vehicle System for Safety Applications

Business Wire

2 years ago

Iteris Launches Cutting-Edge Integrated Detection and Connected Vehicle System for Safety Applications

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

GlobeNewswire

2 years ago

Collective Audience Appoints Technology Visionary, Investor, and Executive Leader, Peter Bordes, as Chief Executive Officer

Yoshitsu Co., Ltd. to Directly Operate its Hong Kong Stores

GlobeNewswire

2 years ago

Yoshitsu Co., Ltd. to Directly Operate its Hong Kong Stores

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Business Wire

2 years ago

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Loop Media (LPTV) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

2 years ago

Loop Media (LPTV) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany

GlobeNewswire

2 years ago

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany

Espey Declares Regular Quarterly Dividend of $0.15 Per Share

GlobeNewswire

2 years ago

Espey Declares Regular Quarterly Dividend of $0.15 Per Share

WidePoint's Subsidiary IT Authorities Awarded New Contract to Provide Managed IT Services

ACCESSWIRE

2 years ago

WidePoint's Subsidiary IT Authorities Awarded New Contract to Provide Managed IT Services

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

GlobeNewswire

2 years ago

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany

GlobeNewswire

2 years ago

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany

WidePoint's Subsidiary IT Authorities Awarded New CISCO Equipment Contract

ACCESSWIRE

2 years ago

WidePoint's Subsidiary IT Authorities Awarded New CISCO Equipment Contract

GlobeNewswire

2 years ago

Diamond Equity Research Releases Update Note on uCloudlink Group Inc. (NASDAQ: UCL)

Insider Buying: CEO Brent Suen Acquires 190,000 Shares of Collective Audience Inc (CAUD)

GuruFocus.com

2 years ago

Insider Buying: CEO Brent Suen Acquires 190,000 Shares of Collective Audience Inc (CAUD)

Has uCloudlink Group Inc.'s (NASDAQ:UCL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.

2 years ago

Has uCloudlink Group Inc.'s (NASDAQ:UCL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts

PR Newswire

2 years ago

Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts

Phoenix New Media Limited (NYSE:FENG) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Phoenix New Media Limited (NYSE:FENG) Q3 2023 Earnings Call Transcript

Collective Audience Appoints Digital Media and Technology Industry Executive, Elisabeth DeMarse, to the Board of Directors

GlobeNewswire

2 years ago

Collective Audience Appoints Digital Media and Technology Industry Executive, Elisabeth DeMarse, to the Board of Directors

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results

Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023

GuruFocus.com

2 years ago

Galectin Therapeutics Inc (GALT) Reports Increased Net Loss in Q3 2023

Creative Media & Community Trust Announces Date for Its Third Quarter 2023 Earnings Release and Conference Call

Business Wire

2 years ago

Creative Media & Community Trust Announces Date for Its Third Quarter 2023 Earnings Release and Conference Call

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

2 years ago

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Where Food Comes From, Inc. (NASDAQ:WFCF) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Where Food Comes From, Inc. (NASDAQ:WFCF) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Sunworks Inc Earnings Call

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire

2 years ago

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers

GlobeNewswire

2 years ago

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers

Yoshitsu Co., Ltd Establishes a New Subsidiary in Canada

GlobeNewswire

2 years ago

Yoshitsu Co., Ltd Establishes a New Subsidiary in Canada

Share on Social Networks: